Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Drug Discovery Today
|
February 19, 2018
Adaptive pathway development for Fabry disease: a clinical approach
Yvonne Schuller, Maarten Arends, Simon Körver, et al.
Journal of Clinical Pharmacology
|
September 8, 2018
Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
Yvonne Schuller, Christine Gispen-de Wied, Carla E M Hollak, et al.
Orphanet Journal of Rare Diseases
|
November 30, 2018
Oncologic orphan drugs approved in the EU - do clinical trial data correspond with real-world effectiveness?
Yvonne Schuller, Marieke Biegstraaten, Carla E M Hollak, et al.
Plos One
|
May 11, 2012
The features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria
Marleen G H van de Sande, Maria J H de Hair, Yvonne Schuller, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Drug Discovery Today
|
February 19, 2018
Adaptive pathway development for Fabry disease: a clinical approach
Yvonne Schuller, Maarten Arends, Simon Körver, et al.
Journal of Clinical Pharmacology
|
September 8, 2018
Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
Yvonne Schuller, Christine Gispen-de Wied, Carla E M Hollak, et al.
Orphanet Journal of Rare Diseases
|
November 30, 2018
Oncologic orphan drugs approved in the EU - do clinical trial data correspond with real-world effectiveness?
Yvonne Schuller, Marieke Biegstraaten, Carla E M Hollak, et al.
Plos One
|
May 11, 2012
The features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria
Marleen G H van de Sande, Maria J H de Hair, Yvonne Schuller, et al.
Page
of 1